Showing results (1-10 of 190) with videos related to
Sort By:
Pageof 19
Cancer Research|October 3, 2007
Definition of functionally important mechanistic differences among selective estrogen receptor down-regulatorsBryan M Wittmann, Andrea Sherk, Donald P McDonnellMolecular Endocrinology (Baltimore, Md.)|March 5, 2002
A negative coregulator for the human ERJohn D Norris, Daju Fan, Andrea Sherk, et al.Proceedings of the National Academy of Sciences of the United States of America|July 4, 2009
Inhibition of prostate cancer cell growth by second-site androgen receptor antagonistsJames D Joseph, Bryan M Wittmann, Mary A Dwyer, et al.Molecular Endocrinology (Baltimore, Md.)|October 29, 2010
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancerSakiko Kobayashi, James P Stice, Dmitri Kazmin, et al.Molecular Cell|November 18, 2009
The homeodomain protein HOXB13 regulates the cellular response to androgensJohn D Norris, Ching-Yi Chang, Bryan M Wittmann, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2026
Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud IrishmanDonald P McDonnellMolecular Endocrinology (Baltimore, Md.)|November 11, 2009
Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulatorsCarolyn D DuSell, Erik R Nelson, Bryan M Wittmann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
The molecular pharmacology of estrogen receptor modulators: implications for the treatment of breast cancerDonald P McDonnellMaturitas|September 1, 2004
The molecular determinants of estrogen receptor pharmacologyDonald P McDonnellProceedings of the National Academy of Sciences of the United States of America|March 11, 2026
Bert W. O'Malley (1936-2025): A great scientist, mentor, and proud IrishmanDonald P McDonnellPageof 19